Type 1 Diabetes Mellitus: Intermediate-acting, Long-acting, and Biosimilar Insulins

    Comparative Efficacy and Safety of Intermediate-acting, Long-acting and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis

     

    Category :

    Date : 29 Oct 2019